1015433-96-1 Usage
Uses
Used in Pharmaceutical Industry:
4,5-Difluoro-2-nitrobenzoic acid methyl ester is used as a key intermediate in the synthesis of pharmaceuticals for its ability to be chemically modified to produce a range of medicinal compounds. Its unique structure allows for the development of drugs with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 4,5-Difluoro-2-nitrobenzoic acid methyl ester serves as an intermediate in the production of agrochemicals, contributing to the creation of pesticides and other agricultural products designed to improve crop yields and protect plants from pests.
Used in Organic Synthesis:
4,5-Difluoro-2-nitrobenzoic acid methyl ester is utilized as a versatile building block in organic synthesis, enabling the formation of a variety of complex organic molecules for research and commercial applications.
Used in Research Applications:
4,5-DIFLUORO-2-NITROBENZOIC ACID METHYL ESTER is also employed in research settings, where its properties and reactivity are studied to further understand chemical reactions and develop new methodologies in organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 1015433-96-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,1,5,4,3 and 3 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1015433-96:
(9*1)+(8*0)+(7*1)+(6*5)+(5*4)+(4*3)+(3*3)+(2*9)+(1*6)=111
111 % 10 = 1
So 1015433-96-1 is a valid CAS Registry Number.
1015433-96-1Relevant articles and documents
PLATELET ADP RECEPTOR INHIBITORS
-
Page/Page column 33, (2008/06/13)
Compounds are provided which are useful as platelet ADP receptor inhibitors, for treating thrombosis and for reducing the likelihood and/or severity of a secondary ischemic event in a patient.
VIRAL POLYMERASE INHIBITORS
-
Page/Page column 63, (2010/11/28)
Compounds of formula (I): wherein X, R2, R3, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase.
2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use
-
Page 55, (2010/02/05)
Selected compounds are effective for treatment of diseases, such as cell proliferation or apoptosis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving stroke, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.